October 12, 2018

Distinguished Alumna Address - Mark Rampy, Ph.D., MBA

12:00 PM

2901 THSL

Mark Rampy, Ph.D. (1995, Counsell lab), MBA, Chief Business Officer, Sequella, Inc.

 

"Use of T-Cells as Therapeutics: Developing “Tailored” Immunotherapies for the Treatment of Cancer"